Lechner MG, Cheng MI, Patel AY, Hoang AT, et al. Inhibition of IL-17A Protects against Thyroid Immune-Related Adverse Events while Preserving Checkpoint Inhibitor Antitumor Efficacy. J Immunol 2022 Jul 11. pii: jimmunol.2200244. doi: 10.4049/jimmunol.2200244.
PMID: 35817515